Plum SEC
  • Korean Market
  • Privacy Policy

Korean Market

  • Reset (View All)

  • ★★★★★
  • ★★★★
  • ★★★
  • ★★
  • ★

  • ★

  • ★
  • ★★
  • ★★★
  • ★★★★
  • ★★★★★
All Disclosures
ISSU
Neuromeka
★

Neuromeka Sets First Issuance Price at 38,350 KRW for 122.6 Billion KRW Rights Offering, CEO's Stake May Drop to 14.26% Raising Dilution Concerns

  06/18/2026 12:57 PM
MATR
Neuromeka
★

Neuromeka Announces 122.6 Billion KRW Rights Offering and 0.5-for-1 Stock Dividend, Diluting Existing Shareholders by 25.76%

  06/18/2026 11:32 AM
EXCH
Neuromeka
★★

Neuromeka Announces First Issue Price of 38,350 Won for 25.76% Rights Offering, Raising Concerns of Shareholder Dilution

  06/18/2026 11:29 AM
EXCH
Neuromeka
★

Neuromeka's Conversion Price Upward Adjustment Reduces Dilution Risk Amid Stock Price Rise

  06/16/2026 04:31 PM
OWNR
Neuromeka
★

Neuromeka CEO Jonghoon Park Plans OTC Sale of Shares and Warrants to Fund Rights Offering Subscription

  06/05/2026 05:41 PM
ISSU
Neuromeka
★★

Neuromeka Decides on 126.6B KRW Rights Offering at 39,600 KRW per Share... Largest Shareholder Stake May Drop to 14.67%, Raising Dilution Concerns

  06/02/2026 05:05 PM
MATR
Neuromeka
★

Neuromeka Announces 126.58B KRW Rights Offering and 50% Stock Dividend - Discounted Issue Price of 39,600 KRW, Risks of Dilution and Price Decline

  06/02/2026 04:25 PM
OWNR
Neuromeka
★

Master Heo Yeong-jin Exercises Stock Options, Stake Slightly Increases to 0.61%... Limited Impact on Minority Shareholders

  05/26/2026 05:21 PM
OWNR
Neuromeka
★

Neuromeka Non-Registered Director Jeong Jong-pil Acquires 7,000 Additional Shares via Stock Option Exercise… Minor Ownership Change, Limited Impact on Shareholder Value

  05/26/2026 05:19 PM
OWNR
Neuromeka
★

Neuromeka Non-Registered Officer Lee Jae-cheon Increases Stake to 0.18% via Stock Option Exercise… Profits from Low Exercise Price

  05/26/2026 05:17 PM
OWNR
Neuromeka
★

Mirae Asset Global Investments Increases Stake in Neuromeka to 5.07% (11,990 Shares via ETF Creation)

  05/21/2026 05:04 PM
ISSU
Neuromeka
★★★

Neuromeka Announces 150 Billion KRW Rights Offering - Aimed at Financial Restructuring and Facility Investment, Significant Dilution Risk

  05/14/2026 05:50 PM
PERI
Neuromeka
★

Neuromeka: Q1 Operating Loss Continues, but Debt Ratio Sharply Improves to 101% Following CB Conversion

  05/14/2026 05:27 PM
EXCH
Neuromeka
★

Decision to Increase Short-term Borrowing by KRW 10 Billion

  05/08/2026 04:48 PM
OWNR
Neuromeka
★

Submission of Mass Holdings Report (Simplified Form)

  05/04/2026 04:33 PM
  • «
  • 1
  • 2
  • »
한국어 | English | 中文 | 日本語
Plum SEC © 2026.05.25
The information provided on this site is for reference only and we do not guarantee its accuracy or completeness. Users are solely responsible for any investment decisions made based on this information.